Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | AR | P10275 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7074676 | 0.92 | L3MBTL1 (0.42) | L3MBTL1SMN1; SMN2ARCYP1A2CYP3A4 | |
| SCHEMBL7074089 | 0.82 | SMN1; SMN2 (0.41) | SMN1; SMN2ARCYP1A2CYP2C19LMNA | |
| SCHEMBL7070749 | 0.79 | SMN1; SMN2 (0.50) | SMN1; SMN2ARGAALMNAMAP4K4 | |
| SCHEMBL7074411 | 0.77 | MEN1 (0.50) | GAALMNAMAP4K4 | |
| SCHEMBL7069974 | 0.76 | PDE4A (0.50) | SMN1; SMN2ARGAAMAP4K4 | |
| SCHEMBL7072557 | 0.76 | PDE4A (0.50) | SMN1; SMN2ARGAAMAP4K4 | |
| SCHEMBL14189347 | 0.75 | L3MBTL1 (0.61) | L3MBTL1SMN1; SMN2ARCYP1A2CYP3A4 | |
| SCHEMBL921247 | 0.75 | SMN1; SMN2 (0.53) | SMN1; SMN2AR | |
| SCHEMBL9767808 | 0.74 | L3MBTL1 (0.75) | L3MBTL1SMN1; SMN2CYP1A2CYP3A4GAA | |
| SCHEMBL7070717 | 0.74 | MEN1 (0.50) | SMN1; SMN2GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030181334-A1 | Herbicidal method | BAYER CROPSCIENCE LIMITED (GB) | 2003-09-25 | — | — | US | disclosed |
| WO-2003051119-A1 | NEW HERBICIDAL COMPOUNDS AND METHOD | BAYER CROPSCIENCE LIMITED (GB) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181334-A1 | Herbicidal method | DDT, HAAO, CYP4X1 | L3MBTL1 2135/4885SMN1; SMN2 4836/4885AR 4356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.